San Francisco start - up Brain Genomics , a Y Combinator graduate , has raised $ 32 m in a series A round led by DFJ . It is developing drugs to treat amyotrophic lateral syndrome ( ALS ) , also known as Lou Gehrig 's disease , by comparing samples of cells from people who have died from the disease with those of healthy brains and also uses mice to study human diseases . Its teams then use machine - learning algorithms to identify the genes triggering ALS . The company is focusing on finding chemical molecules that can be turned into drugs , and aims to expand its research to include Parkinson ’s disease .
San Francisco start-up Verge Genomics, a Y Combinator graduate, has raised $32m in a series A funding led by DFJ. Verge is developing drugs to treat amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease, by comparing samples of cells from people who have died from the disease with those of healthy brains and also uses mice to study human diseases. Its teams then use machine-learning algorithms to identify the genes triggering ALS. The company is focusing on finding chemical molecules that can be turned into drugs, and aims to expand its research to include Parkinson’s disease.